Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Post-acute brain injury urinary signature: a new resource for molecular diagnostics.

Ottens AK, Stafflinger JE, Griffin HE, Kunz RD, Cifu DX, Niemeier JP.

J Neurotrauma. 2014 Apr 15;31(8):782-8. doi: 10.1089/neu.2013.3116. Epub 2014 Mar 6.

2.

Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.

Wolahan SM, Hirt D, Glenn TC.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25.

3.

Urinary Biomarkers of Brain Diseases.

An M, Gao Y.

Genomics Proteomics Bioinformatics. 2015 Dec;13(6):345-54. doi: 10.1016/j.gpb.2015.08.005. Epub 2016 Jan 2. Review.

4.

Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury.

Orešič M, Posti JP, Kamstrup-Nielsen MH, Takala RSK, Lingsma HF, Mattila I, Jäntti S, Katila AJ, Carpenter KLH, Ala-Seppälä H, Kyllönen A, Maanpää HR, Tallus J, Coles JP, Heino I, Frantzén J, Hutchinson PJ, Menon DK, Tenovuo O, Hyötyläinen T.

EBioMedicine. 2016 Oct;12:118-126. doi: 10.1016/j.ebiom.2016.07.015. Epub 2016 Jul 15.

5.

Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children.

Newell E, Shellington DK, Simon DW, Bell MJ, Kochanek PM, Feldman K, Bayir H, Aneja RK, Carcillo JA, Clark RS.

Pediatr Crit Care Med. 2015 Jul;16(6):549-57. doi: 10.1097/PCC.0000000000000400.

6.

Effect of associated injuries and blood volume replacement on death, rehabilitation needs, and disability in blunt traumatic brain injury.

Siegel JH, Gens DR, Mamantov T, Geisler FH, Goodarzi S, MacKenzie EJ.

Crit Care Med. 1991 Oct;19(10):1252-65.

PMID:
1914482
7.

Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.

Shore PM, Berger RP, Varma S, Janesko KL, Wisniewski SR, Clark RS, Adelson PD, Thomas NJ, Lai YC, Bayir H, Kochanek PM.

J Neurotrauma. 2007 Jan;24(1):75-86.

PMID:
17263671
8.

Animal Models for Concussion: Molecular and Cognitive Assessments—Relevance to Sport and Military Concussions.

Bolouri H, Zetterberg H.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 46.

9.

Urinary S100B concentrations are increased after brain injury in children: A preliminary study.

Berger RP, Kochanek PM.

Pediatr Crit Care Med. 2006 Nov;7(6):557-61.

PMID:
17006387
10.

Neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury in patients with traumatic brain injury.

Li N, Zhao WG, Xu FL, Zhang WF, Gu WT.

J Nephrol. 2013 Nov-Dec;26(6):1083-8. doi: 10.5301/jn.5000282. Epub 2013 Oct 3.

PMID:
24249209
11.

Autoantibodies in CNS Trauma and Neuropsychiatric Disorders: A New Generation of Biomarkers.

Kobeissy F, Moshourab RA.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 29.

12.

Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury.

Jha RM, Puccio AM, Chou SH, Chang CH, Wallisch JS, Molyneaux BJ, Zusman BE, Shutter LA, Poloyac SM, Janesko-Feldman KL, Okonkwo DO, Kochanek PM.

Crit Care Med. 2017 Mar;45(3):e255-e264. doi: 10.1097/CCM.0000000000002079.

PMID:
27845954
13.

Blood-based diagnostics of traumatic brain injuries.

Mondello S, Muller U, Jeromin A, Streeter J, Hayes RL, Wang KK.

Expert Rev Mol Diagn. 2011 Jan;11(1):65-78. doi: 10.1586/erm.10.104. Review.

14.

Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase.

Giannantoni A, Silvestro D, Siracusano S, Azicnuda E, D'Ippolito M, Rigon J, Sabatini U, Bini V, Formisano R.

Arch Phys Med Rehabil. 2011 Jul;92(7):1134-8. doi: 10.1016/j.apmr.2011.02.013.

PMID:
21704794
15.

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

Pineda JA, Lewis SB, Valadka AB, Papa L, Hannay HJ, Heaton SC, Demery JA, Liu MC, Aikman JM, Akle V, Brophy GM, Tepas JJ, Wang KK, Robertson CS, Hayes RL.

J Neurotrauma. 2007 Feb;24(2):354-66.

PMID:
17375999
16.

Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity.

Robertson CL, Bell MJ, Kochanek PM, Adelson PD, Ruppel RA, Carcillo JA, Wisniewski SR, Mi Z, Janesko KL, Clark RS, Marion DW, Graham SH, Jackson EK.

Crit Care Med. 2001 Dec;29(12):2287-93.

PMID:
11801827
17.

A metabolomic analytical approach permits identification of urinary biomarkers for Plasmodium falciparum infection: a case-control study.

Abdelrazig S, Ortori CA, Davey G, Deressa W, Mulleta D, Barrett DA, Amberbir A, Fogarty AW.

Malar J. 2017 May 30;16(1):229. doi: 10.1186/s12936-017-1875-z.

18.

Significant elevation of urinary trypsin inhibitor in patients with brain contusion--a preliminary report.

Sakai K, Okudera H, Hongo K.

J Clin Neurosci. 2003 Nov;10(6):677-9.

PMID:
14592616
19.

Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury.

Bahrami S, Pelinka L, Khadem A, Maitzen S, Hawa G, van Griensven M, Redl H.

Crit Care Med. 2010 Jan;38(1):161-6. doi: 10.1097/CCM.0b013e3181b78a06.

PMID:
19730251
20.

Modeling the Neurobehavioral Consequences of Blast-Induced Traumatic Brain Injury Spectrum Disorder and Identifying Related Biomarkers.

Agoston DV, Kamnaksh A.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 23.

Supplemental Content

Support Center